Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Gentile

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Epidemiologia E Prevenzione|October 30, 2018
[Organ donation and transplantation: the "friendly access initiative" in the Federico II Hospital (Naples), between nudging and narrative medicine]Teresa De Pascale, Rossella Alfano, Oriana Barbieri, et al.
European Journal of Neurology|October 30, 2024
Association between CD20<sup>+</sup> T lymphocytes and neuropsychological findings in multiple sclerosisAntonio Esposito, Fabrizia Falco, Giulia Scalia, et al.
International Journal of Cancer|September 30, 2016
HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancerGina S Ogilvie, Mel Krajden, Dirk van Niekerk, et al.
Iscience|September 18, 2023
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanomaLorella Tripodi, Sara Feola, Ilaria Granata, et al.
British Journal of Cancer|November 18, 2016
Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trialAndrew J Coldman, Lovedeep Gondara, Laurie W Smith, et al.
JAMA|July 5, 2018
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical TrialGina Suzanne Ogilvie, Dirk van Niekerk, Mel Krajden, et al.
International Journal of Cancer|June 28, 2019
Disease detection at the 48-month exit round of the HPV FOCAL cervical cancer screening trial in women per-protocol eligible for routine screeningAndrew J Coldman, Dirk van Niekerk, Mel Krajden, et al.
Journal of the Canadian Association of Gastroenterology|August 14, 2024
Canadian colorectal cancer screening programs: How do they measure up using the International Agency for Research on Cancer criteria for organized screening?Cindy C Y Law, Li Zhang, André L Carvalho, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Epidemiologia E Prevenzione|October 30, 2018
[Organ donation and transplantation: the "friendly access initiative" in the Federico II Hospital (Naples), between nudging and narrative medicine]Teresa De Pascale, Rossella Alfano, Oriana Barbieri, et al.
European Journal of Neurology|October 30, 2024
Association between CD20<sup>+</sup> T lymphocytes and neuropsychological findings in multiple sclerosisAntonio Esposito, Fabrizia Falco, Giulia Scalia, et al.
International Journal of Cancer|September 30, 2016
HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancerGina S Ogilvie, Mel Krajden, Dirk van Niekerk, et al.
Iscience|September 18, 2023
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanomaLorella Tripodi, Sara Feola, Ilaria Granata, et al.
British Journal of Cancer|November 18, 2016
Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trialAndrew J Coldman, Lovedeep Gondara, Laurie W Smith, et al.
JAMA|July 5, 2018
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical TrialGina Suzanne Ogilvie, Dirk van Niekerk, Mel Krajden, et al.
International Journal of Cancer|June 28, 2019
Disease detection at the 48-month exit round of the HPV FOCAL cervical cancer screening trial in women per-protocol eligible for routine screeningAndrew J Coldman, Dirk van Niekerk, Mel Krajden, et al.
Journal of the Canadian Association of Gastroenterology|August 14, 2024
Canadian colorectal cancer screening programs: How do they measure up using the International Agency for Research on Cancer criteria for organized screening?Cindy C Y Law, Li Zhang, André L Carvalho, et al.
Pageof 3